510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K980900Substantially Equivalent

N-Assay Cpk-L

Crestat Diagnostics, Inc., Seattle WA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K980900 is the FDA 510(k) clearance record for N-ASSAY CPK-L, a class II device, cleared for Crestat Diagnostics, Inc. on under FDA product code CGS (Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes). FDA records list 29 510(k) clearances for Crestat Diagnostics, Inc., from to . As of , FDA records show no recalls naming K980900.

Clearance record

Decision date
Received
(16 days to decision)
Product code
CGS Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes
Regulation
21 CFR 862.1215
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Crestat Diagnostics, Inc. 910 Industry Dr., Seattle WA
510(k) summary
Summary
Third party review
No

Clearances, product code CGS

Trailing 12 months

FDA records hold no clearances under product code CGS in the trailing twelve months.

FDA records show no clearances under product code CGS in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CGS, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260